SLC7A9 and neoplasm: The growth of tumours with high expression levels of SLC7A9 was less affected by erastin treatment than the growth of tumours with low SLC7A9 expression levels (p = 0.0013; Fig. 7d and Supplementary Fig. S6a and b, Student’s t-test).